We narrowed to 18,241 results for: RET

#161358

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#221415

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

July 18, 2024

Academic Institutions and Nonprofits only

#221417

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

July 18, 2024

Academic Institutions and Nonprofits only

#104992

This 3rd generation lentiviral plasmid expresses a S. pyogenes CRISPR chimeric RNA element with customizable sgRNA from a U6 promoter and G418 (neomycin) resistance from an EF-1a promoter.

Brett Stringer

Stringer et al Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.

Aug. 10, 2018

Academic Institutions and Nonprofits only

#23395

William Hahn, David Root

Johannessen et al Nature. 2010 Dec 16;468(7326):968-72. do

July 30, 2010

Academic Institutions and Nonprofits only

#23869

William Hahn, David Root

Johannessen et al Nature. 2010 Dec 16;468(7326):968-72. do

July 30, 2010

Academic Institutions and Nonprofits only

#110280

Doxycycline-inducible overexpression of Sox2

Trudy Oliver

Mollaoglu et al Immunity. 2018 Oct 16;49(4):764-779.e9.

Oct. 16, 2018

Academic Institutions and Nonprofits only

#23668

William Hahn, David Root

Johannessen et al Nature. 2010 Dec 16;468(7326):968-72. do

July 30, 2010

Academic Institutions and Nonprofits only